TP53 and diabetes mellitus: According to a subgroup analysis of gender, drinking habits, diabetes status, pancreatitis, nodal metastasis status, and TP53 mutation, the transcription level of IGF2BP3 in PAAD patients had a higher percentage as compared to healthy people (Figures 7(a)–7(f)).